A Dual-Targeting, Multi-Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm

A Dual-Targeting, Multi-Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 33 vom: 15. Aug., Seite e2405761
1. Verfasser: Mo, Fandi (VerfasserIn)
Weitere Verfasser: Wang, Chufan, Li, Shiyi, Li, Zheyun, Xiao, Cheng, Zhang, Yuchong, Hu, Chengkai, Wang, Enci, Lin, Peng, Yuan, Tong, Zuo, Ziang, Fu, Weiguo, Chen, Xiaoyuan, Ren, Lei, Wang, Lixin
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article abdominal aortic aneurysm autophagy macrophage polarization single cell RNA sequencing smooth muscle cell dysfunction virus‐like nanocage Biocompatible Materials Everolimus 9HW64Q8G6G mehr... Integrin alphaVbeta3 Oligopeptides
LEADER 01000caa a22002652 4500
001 NLM374113424
003 DE-627
005 20240815232405.0
007 cr uuu---uuuuu
008 240627s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202405761  |2 doi 
028 5 2 |a pubmed24n1502.xml 
035 |a (DE-627)NLM374113424 
035 |a (NLM)38923441 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Mo, Fandi  |e verfasserin  |4 aut 
245 1 2 |a A Dual-Targeting, Multi-Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 15.08.2024 
500 |a Date Revised 15.08.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2024 Wiley‐VCH GmbH. 
520 |a Abdominal aortic aneurysm (AAA) is a highly lethal cardiovascular disease that currently lacks effective pharmacological treatment given the complex pathophysiology of the disease. Here, single-cell RNA-sequencing data from patients with AAA and a mouse model are analyzed, which reveals pivotal pathological changes, including the M1-like polarization of macrophages and the loss of contractile function in smooth muscle cells (SMCs). Both cell types express the integrin αvβ3, allowing for their dual targeting with a single rationally designed molecule. To this end, a biocompatible nanodrug, which is termed EVMSR-HNC, that consists of the multifunctional drug everolimus (EVMS) encapsulated by the hepatitis B virus core protein modifies to contain the RGD sequence to specifically bind to integrin αvβ3 is designed. Both in vitro and in vivo results show that EVMS@R-HNC can target macrophages as well as SMCs. Upon binding of the nanodrug, the EVMS is released intracellularly where it exhibits multiple functions, including inhibiting M1 macrophage polarization, thereby suppressing the self-propagating inflammatory cascade and immune microenvironment imbalance, while preserving the normal contractile function of SMCs. Collectively, these results suggest that EVMS@R-HNC presents a highly promising therapeutic approach for the management of AAA 
650 4 |a Journal Article 
650 4 |a abdominal aortic aneurysm 
650 4 |a autophagy 
650 4 |a macrophage polarization 
650 4 |a single cell RNA sequencing 
650 4 |a smooth muscle cell dysfunction 
650 4 |a virus‐like nanocage 
650 7 |a Biocompatible Materials  |2 NLM 
650 7 |a Everolimus  |2 NLM 
650 7 |a 9HW64Q8G6G  |2 NLM 
650 7 |a Integrin alphaVbeta3  |2 NLM 
650 7 |a Oligopeptides  |2 NLM 
700 1 |a Wang, Chufan  |e verfasserin  |4 aut 
700 1 |a Li, Shiyi  |e verfasserin  |4 aut 
700 1 |a Li, Zheyun  |e verfasserin  |4 aut 
700 1 |a Xiao, Cheng  |e verfasserin  |4 aut 
700 1 |a Zhang, Yuchong  |e verfasserin  |4 aut 
700 1 |a Hu, Chengkai  |e verfasserin  |4 aut 
700 1 |a Wang, Enci  |e verfasserin  |4 aut 
700 1 |a Lin, Peng  |e verfasserin  |4 aut 
700 1 |a Yuan, Tong  |e verfasserin  |4 aut 
700 1 |a Zuo, Ziang  |e verfasserin  |4 aut 
700 1 |a Fu, Weiguo  |e verfasserin  |4 aut 
700 1 |a Chen, Xiaoyuan  |e verfasserin  |4 aut 
700 1 |a Ren, Lei  |e verfasserin  |4 aut 
700 1 |a Wang, Lixin  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 33 vom: 15. Aug., Seite e2405761  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:36  |g year:2024  |g number:33  |g day:15  |g month:08  |g pages:e2405761 
856 4 0 |u http://dx.doi.org/10.1002/adma.202405761  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 33  |b 15  |c 08  |h e2405761